Atorvastatin Calcium
Product Images NDC 50090-4913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-4913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
This is a chart that shows the cumulative hazard percentage for Atorvastatin. The hazard ratio for Atorvastatin is 0.53 (95% CI 0.45-0.83) and it is maintained up to 4 years of follow-up.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
The text describes a graph or chart showing the percentage of subjects who experienced "E vert" (it is not clear what this refers to) in relation to two different medications: Horvastatin 10 mg and Sorvastatin 80 mg. The graph shows that Horvastatin had a lower percentage of subjects experiencing E vert, with a hazard ratio of 0.78 and a p-value of 0.0002. The rest of the text appears to be labels for the graph, indicating that it shows the time to the first major cardiovascular endpoint in years (labeled 1-4).*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
FDA Label Image

Label Image (Lbl500904913)

Label Image (Lbl500904913)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.